Skip to main content

Closed

TRIB: Trinity Biotech plc Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-28.6% / yr

Operating margin-25.7%

ROIC-15.1%

Financially safe

Stretched

Debt / equity-1.92×

Interest coverage-0.5×

Current ratio0.25×

Trinity Biotech plc

TRIBNASDAQ Global Select·USD·Closed

Trinity Biotech plc

TRIBNASDAQ·USD·Closed

$11.60

−9.02%

$11.60

−$1.15 (9.02%)

52W Range

4thpctl

Volume

0.27×avg

Mkt Cap

234.91MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.27×avg

Market Cap

234.91MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings